Hostname: page-component-8448b6f56d-t5pn6 Total loading time: 0 Render date: 2024-04-17T07:43:43.757Z Has data issue: false hasContentIssue false
  • English
  • Français

Vitamin D and muscle function in adolescents from the Young Hearts study

Published online by Cambridge University Press:  28 August 2013

E. L. Carson ,
L. K. Pourshahidi ,
C. A. Boreham ,
J. J. Strain  and
M. S. Mulhern
E. L. Carson
Affiliation:
Northern Ireland Centre for Food and Health (NICHE), University of Ulster, Coleraine, BT52 1SA
L. K. Pourshahidi
Affiliation:
Northern Ireland Centre for Food and Health (NICHE), University of Ulster, Coleraine, BT52 1SA
C. A. Boreham
Affiliation:
Cardiovascular Research Centre, Queen's University Belfast, Belfast, BT7 1NN
J. J. Strain
Affiliation:
Northern Ireland Centre for Food and Health (NICHE), University of Ulster, Coleraine, BT52 1SA
M. S. Mulhern
Affiliation:
Northern Ireland Centre for Food and Health (NICHE), University of Ulster, Coleraine, BT52 1SA
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.
Type
Abstract
Information
Proceedings of the Nutrition Society , Volume 72 , Issue OCE3: Irish Section Meeting, 19–21 June 2013, Childhood nutrition and obesity: current status and future challenges , 2013 , E115
Copyright
Copyright © The Authors 2013 

Low vitamin D status has been associated with impaired muscle strength and function( Reference Gallagher 1 ), which can be corrected, in some cases, by repletion of vitamin D status( Reference Stockton, Mengersen and Paratz 2 ). Most studies have been conducted in elderly populations, investigating the prevention of age-related muscle loss( Reference Wicherts, van Schoor and Boeke 3 , Reference Houston, Tooze and Hausman4 ). There is a dearth of studies considering the effect of vitamin D status on muscle gain during adolescence, a critical period for growth( Reference Foo, Zhang and Zhu 5 , Reference Ward, Das and Roberts6 ). The aim of the current study is to investigate the associations between vitamin D status and fat free mass (FFM), muscle strength and muscle power in 12 and 15 year old adolescents from the Young Hearts Study.

The Young Hearts Study is a representative sample (n 2017) of 12 and 15 year old Northern Irish males and females, recruited during 1999–2001. Of the main cohort, a total of 1015 adolescents had serum 25-hydroxyvitamin D (25(OH)D) concentrations available for the current analysis, quantified using enzyme linked immuno assay (OCTEIA®, IDS, Ltd., UK.) Total skinfolds (TS; mm) were determined by measurements taken at 4 sites (biceps, triceps, suprailiac and subscapular), and were used to calculate absolute FFM (kg), as well as FFM relative to total body weight (%). Sargent jump test results were used to calculate peak power (W), using the Sayer's Equation. Muscle strength was measured by hand grip dynamometry (Takei Scientific Instrument Company Limited, Japan).

* Significant association with 25(OH)D concentration (P 0.05, linear regression), including physical activity as a covariate in each model. FFM (%) was included as an additional covariate in strength and power models.

Serum 25(OH)D concentrations were negatively associated with peak power, in 12 year old females only, and positively associated with strength in 15 year old males only. Vitamin D status was not a significant predictor of FFM or TS in any age-sex group. The difference between age-sex groups may reflect a fast changing hormone profile in males and females at this stage of life. These results add to the literature within the area of vitamin D and muscle function in adolescents and further research to investigate possible mechanisms is warranted in this population.

This work was funded by the Department for Employment and Learning. Ethical approval was obtained from the Research Ethics Committee, Queen's University Belfast and the study was conducted according to the guidelines laid down in the Declaration of Helsinki.

References

1. Gallagher, JC (2012) J Clin Endocrinol Metab 97, 4366–4369.CrossRefGoogle Scholar
2. Stockton, KA, Mengersen, K, Paratz, JD et al. (2011) Osteoporos Int 22, 859–871.Google Scholar
3. Wicherts, IS, van Schoor, NM, Boeke, AJ et al. (2007) J Clin Endocrinol Metab 92, 2058–2065.Google Scholar
4. Houston, DK, Tooze, JA, Hausman, DB et al. (2011) J Gerentol A Biol Sci Med Sci 66, 430–436.Google Scholar
5. Foo, LH, Zhang, Q, Zhu, K et al. (2009) Nut Epidemiol 139, 1002–1007.Google Scholar
6. Ward, KA, Das, G, Roberts, SA et al. (2010) J Clin Endocrinol Metab 95, 4643–4651.Google Scholar
Figure 0

*